NDC 72275-708

Lidovix Delayed Release

Lidocaine, Diclofenac Sodium

Lidovix Delayed Release is a Oral; Topical Kit in the Human Prescription Drug category. It is labeled and distributed by Primary Pharmaceuticals, Inc.. The primary component is .

• Product ID: 72275-708_8f896469-4df2-599c-e053-2a95a90ac924
• NDC: 72275-708
• Product Type: Human Prescription Drug
• Proprietary Name: Lidovix Delayed Release
• Generic Name: Lidocaine, Diclofenac Sodium
• Dosage Form: Kit
• Route of Administration: ORAL; TOPICAL
• Marketing Start Date: 2019-08-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Primary Pharmaceuticals, Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 72275-708-77

1 BOX in 1 CARTON (72275-708-77) > 1 BOTTLE in 1 BOX > 1 KIT in 1 BOTTLE * 60 TABLET, DELAYED RELEASE in 1 BOTTLE * 30 POUCH in 1 CARTON (0591-3525-30) > 1 g in 1 POUCH

• Marketing Start Date: 2019-08-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72275-708-77 [72275070877]

Lidovix Delayed Release KIT

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-08-01

Drug Details

OpenFDA Data

• SPL SET ID: 8f880f4b-07b1-3650-e053-2995a90a5549
• Manufacturer:
  • Primary Pharmaceuticals, Inc.
• RxNorm Concept Unique ID - RxCUI:
  • 1745091
  • 855926